Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

GTHRX vs. QAAGZX: which is better?

Bottom line

GTHRX vs QAAGZX: the short answer

GTHRX (INVESCO Health Care Fund) and QAAGZX (T. Rowe Price Health Sciences Portfolio) are both mutual funds.

But QAAGZX is far broader, holding 277 positions to 82 for GTHRX, so beyond the top names it adds exposure GTHRX doesn't have.

QAAGZX is cheaper at 0.86% vs 1.32% — a difference of $46 a year per $10,000 invested.

Over five years, QAAGZX returned +4.1% a year vs +3.5% for GTHRX.

Updated Nov 19, 2026

GTHRX vs QAAGZX side by side

GTHRXQAAGZX
TypeMutual fundETF
Fund familyInvescoT. Rowe Price
CategoryHealth Care SectorHealth Care Sector
Expense ratio1.32%0.86%
Annual cost per $10k$132$86
10-yr cost on $10k (prospectus)$1,590$1,061
Max front load0%None
12b-1 fee0.5%0%
1-yr return+15.2%+18.1%
5-yr return (annualized)+3.5%+4.1%
10-yr return (annualized)+6.1%+9.0%
Best quarter+19.6%+23.4%
Worst quarter−16.5%−15.8%
Net assets (fund)$1.2B$751.7M
Number of holdings82277
Portfolio turnover59%65%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearGTHRXQAAGZXDifference
2024+4.0%+1.7%+2.3%
2023+3.1%+3.0%+0.1%
2022−13.5%−12.5%−1.1%
2021+12.2%+13.1%−0.9%
2020+14.5%+29.6%−15.2%
2019+32.0%+29.0%+3.1%
2018+0.5%+1.1%−0.7%
2017+15.5%+27.6%−12.1%
2016−11.7%−10.5%−1.2%

Source: Fund prospectus bar charts

Holdings overlap

11 of GTHRX's top 25 holdings also appear in QAAGZX's top 25.

Shared top holdings
HoldingGTHRXQAAGZX
Eli Lilly and Co.10.59%14.06%
Johnson & Johnson6.76%6.64%
UnitedHealth Group Inc.6.17%5.88%
Merck & Co., Inc.4.59%4.00%
AbbVie Inc.4.03%5.12%
Gilead Sciences, Inc.3.63%2.79%
CVS Health Corp.2.52%0.93%
Cardinal Health, Inc.2.10%1.04%
Guardant Health, Inc.2.04%1.22%
Vertex Pharmaceuticals Inc.2.01%2.26%
Thermo Fisher Scientific Inc.1.55%2.53%

Source: SEC Form N-PORT

GTHRX top 10

  1. Eli Lilly and Co. — 10.59%
  2. Johnson & Johnson — 6.76%
  3. UnitedHealth Group Inc. — 6.17%
  4. Invesco Private Prime Fund — 4.67%
  5. Merck & Co., Inc. — 4.59%
  6. AbbVie Inc. — 4.03%
  7. Gilead Sciences, Inc. — 3.63%
  8. argenx SE — 3.24%
  9. CVS Health Corp. — 2.52%
  10. Welltower Inc. — 2.34%

QAAGZX top 10

  1. Eli Lilly & Co — 14.06%
  2. Johnson & Johnson — 6.64%
  3. Unitedhealth Group Inc — 5.88%
  4. Abbvie Inc — 5.12%
  5. Merck & Co. Inc. — 4.00%
  6. Gilead Sciences Inc — 2.79%
  7. Thermo Fisher Scientific Inc — 2.53%
  8. Vertex Pharmaceuticals Inc — 2.26%
  9. Bristol-myers Squibb Co — 2.12%
  10. Abbott Laboratories — 1.91%

FAQ

What is the difference between GTHRX and QAAGZX?
GTHRX (INVESCO Health Care Fund) and QAAGZX (T. Rowe Price Health Sciences Portfolio) are both mutual funds. But QAAGZX is far broader, holding 277 positions to 82 for GTHRX, so beyond the top names it adds exposure GTHRX doesn't have.
Which is cheaper, GTHRX or QAAGZX?
QAAGZX has the lower expense ratio (0.86%).
Should I own both GTHRX and QAAGZX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.